Header Logo

Connection

WILLIAM MITCH to Renal Insufficiency, Chronic

Back to Details
This is a "connection" page, showing publications WILLIAM MITCH has written about Renal Insufficiency, Chronic.
WILLIAM MITCH
Connection Strength
5.177
Renal Insufficiency, Chronic
  1. Muscle Atrophy in CKD: A Historical Perspective of Advancements in Its Understanding. J Ren Nutr. 2023 11; 33(6S):S88-S92.
    View in: PubMed
    Score: 0.441
  2. Mechanisms Regulating Muscle Protein Synthesis in CKD. J Am Soc Nephrol. 2020 11; 31(11):2573-2587.
    View in: PubMed
    Score: 0.380
  3. Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease. Am J Physiol Renal Physiol. 2020 07 01; 319(1):F84-F92.
    View in: PubMed
    Score: 0.376
  4. Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40. Am J Physiol Endocrinol Metab. 2020 05 01; 318(5):E625-E635.
    View in: PubMed
    Score: 0.369
  5. Diets for patients with chronic kidney disease, should we reconsider? BMC Nephrol. 2016 07 11; 17(1):80.
    View in: PubMed
    Score: 0.287
  6. Low-protein diets in chronic kidney disease: are we finally reaching a consensus? Nephrol Dial Transplant. 2015 Jan; 30(1):6-8.
    View in: PubMed
    Score: 0.255
  7. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014 Sep; 10(9):504-16.
    View in: PubMed
    Score: 0.249
  8. Signal regulatory protein-a interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int. 2013 Aug; 84(2):308-16.
    View in: PubMed
    Score: 0.228
  9. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin. Clin Exp Nephrol. 2013 Apr; 17(2):174-82.
    View in: PubMed
    Score: 0.225
  10. Decreased miR-29 suppresses myogenesis in CKD. J Am Soc Nephrol. 2011 Nov; 22(11):2068-76.
    View in: PubMed
    Score: 0.206
  11. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol. 2010 Mar; 21(3):419-27.
    View in: PubMed
    Score: 0.183
  12. Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol. 2008 Apr; 23(4):527-35.
    View in: PubMed
    Score: 0.157
  13. Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation. J Clin Invest. 2023 10 02; 133(19).
    View in: PubMed
    Score: 0.118
  14. SIRPa Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease. Circ Res. 2022 07 22; 131(3):207-221.
    View in: PubMed
    Score: 0.108
  15. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol. 2022 03; 18(3):138-152.
    View in: PubMed
    Score: 0.104
  16. PDGFRA in vascular adventitial MSCs promotes neointima formation in arteriovenous fistula in chronic kidney disease. JCI Insight. 2020 11 05; 5(21).
    View in: PubMed
    Score: 0.097
  17. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial. Am J Kidney Dis. 2020 02; 75(2):225-234.
    View in: PubMed
    Score: 0.090
  18. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. J Cachexia Sarcopenia Muscle. 2019 12; 10(6):1210-1227.
    View in: PubMed
    Score: 0.089
  19. Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients. JCI Insight. 2017 11 16; 2(22).
    View in: PubMed
    Score: 0.079
  20. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun. 2017 11 14; 8(1):1493.
    View in: PubMed
    Score: 0.079
  21. The IL-4 receptor a has a critical role in bone marrow-derived fibroblast activation and renal fibrosis. Kidney Int. 2017 12; 92(6):1433-1443.
    View in: PubMed
    Score: 0.077
  22. AMP-activated protein kinase/myocardin-related transcription factor-A signaling regulates fibroblast activation and renal fibrosis. Kidney Int. 2018 01; 93(1):81-94.
    View in: PubMed
    Score: 0.077
  23. Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting. Curr Opin Clin Nutr Metab Care. 2017 May; 20(3):153-157.
    View in: PubMed
    Score: 0.076
  24. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017 01; 91(1):119-128.
    View in: PubMed
    Score: 0.073
  25. Adherence to ketoacids/essential amino acids-supplemented low protein diets and new indications for patients with chronic kidney disease. BMC Nephrol. 2016 07 07; 17(1):63.
    View in: PubMed
    Score: 0.072
  26. In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia. Kidney Int. 2016 May; 89(5):973-975.
    View in: PubMed
    Score: 0.071
  27. CKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation. J Am Soc Nephrol. 2016 Feb; 27(2):509-19.
    View in: PubMed
    Score: 0.066
  28. Migration of smooth muscle cells from the arterial anastomosis of arteriovenous fistulas requires Notch activation to form neointima. Kidney Int. 2015 Sep; 88(3):490-502.
    View in: PubMed
    Score: 0.065
  29. Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis. Am J Pathol. 2015 May; 185(5):1234-50.
    View in: PubMed
    Score: 0.065
  30. Blocking Notch in endothelial cells prevents arteriovenous fistula failure despite CKD. J Am Soc Nephrol. 2014 Apr; 25(4):773-83.
    View in: PubMed
    Score: 0.061
  31. Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients? Semin Dial. 2013 Nov-Dec; 26(6):714-9.
    View in: PubMed
    Score: 0.059
  32. Stat3 activation links a C/EBPd to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013 Sep 03; 18(3):368-79.
    View in: PubMed
    Score: 0.059
  33. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar; 23(2):77-90.
    View in: PubMed
    Score: 0.057
  34. The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines. Kidney Int. 2013 Apr; 83(4):724-32.
    View in: PubMed
    Score: 0.056
  35. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol. 2009 Mar; 20(3):604-12.
    View in: PubMed
    Score: 0.043
  36. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 2008 Feb; 149(2):827-35.
    View in: PubMed
    Score: 0.039
  37. Notch signaling in bone marrow-derived FSP-1?cells initiates neointima formation in arteriovenous?fistulas. Kidney Int. 2019 06; 95(6):1347-1358.
    View in: PubMed
    Score: 0.021
  38. Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis. Adv Chronic Kidney Dis. 2017 05; 24(3):150-153.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.